Similar Items: Characterization of efflux pumps genes involved in second-line drug resistance of tuberculosis
- Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
- Defining the role of efflux pump inhibitors on anti-TB drugs in Rifampicin resistant clinical Mycobacterium Tuberculosis isolates
- Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
- Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Optimising the efficacy of clofazimine against biofilm-encased Mycobacterium tuberculosis
Author: Fourie, Petrus Bernardus
- Innovative approaches to tuberculosis diagnosis with emphasis on nucleic acid amplification tests in a resource constrained high burden tuberculosis setting
- Antimicrobial, synergistic and autophagic effects of medicines for Malaria venture pathogen box compounds on resistant strains of Mycobacterium tuberculosis and Neisseria gonorrhoeae
- Characterization of efflux pumps genes involved in second-line drug resistance of tuberculosis
- Evaluation of Mycobacterium tuberculosis clinical isolates with discordant rifampicin genotypic and phenotypic susceptibility testing results from Pretoria South Africa